Altimmune Inc.
ALT | NASDAQ
$3.27
+$0.02 (+0.62%)
At close: Sep 21, 2026, 4:00 PM ET
$3.39
+$0.12 (+3.67%)
Pre-market:
Sep 22, 2026, 8:50 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -3.61 | -5.38 | -6.78 | -9.09 | -3.90 | -5.91 |
PEG Ratio | 0.14 | 0.28 | 0.82 | 0.40 | -0.17 | -0.26 |
PS Ratio | 7.76K | 25.6K | 1.41K | -11.35K | 85.75 | 35.33 |
PB Ratio | 1.41 | 4.14 | 3.09 | 4.17 | 1.90 | 1.28 |
P/FCF Ratio | -4.71 | -6.41 | -7.90 | -12.31 | -4.18 | -8.35 |
P/OCF Ratio | -4.71 | -6.41 | -7.90 | -12.33 | -4.83 | -8.43 |
OCF/S Ratio | -164.72K | -399.24K | -17.8K | 92.04K | -1.77K | -419.13 |
Debt / Equity Ratio | 0.16 | 0.01 | 0 | 0.01 | 0.01 | 0.01 |
Quick Ratio | 18.55 | 13.11 | 17.26 | 11.31 | 11.17 | 19.16 |
Current Ratio | 18.55 | 13.11 | 17.26 | 11.31 | 11.17 | 19.16 |
Asset Turnover | 0 | 0 | 0 | 0 | 0.02 | 0.03 |
Interest Coverage | -57.76 | -11.46K | -2.74K | -10.97K | -19.38K | -5.82K |
Return on Equity | -39.17% | -76.97% | -45.57% | -45.72% | -48.76% | -21.71% |
Return on Assets | -31.47% | -68.24% | -41.99% | -40.94% | -44.36% | -20.01% |
Return on Invested Capital | -35.36% | -79.91% | -48.21% | -45.99% | -48.22% | -23.47% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100% | 100% | 100% | 100% | 100% | -309.40% |
Net Profit Margin | -214.86K% | -475.3K% | -20.76K% | 124.58K% | -2.2K% | -599.20% |
Pretax Profit Margin | -216.52K% | -475.3K% | -20.76K% | 124.87K% | -2.2K% | -533.02% |
Operating Profit Margin | -230.46K% | -515.86K% | -22.52K% | 129.03K% | -2.2K% | -669.50% |
FCF Margin | -164.75K% | -399.24K% | -17.81K% | 92.22K% | -2.05K% | -423.31% |
EBITDA Margin | -212.26K% | -474.06K% | -20.64K% | 124.13K% | -2.19K% | -465.54% |
Add to Watchlist
Select watchlists to add or remove ALT